Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12–15 Months

BACKGROUND: M-M-R(TM)II (MMRII; Merck & Co) is currently the only measles-mumps-rubella (MMR) vaccine licensed in the United States. Another licensed vaccine would reinforce MMR supply. This study assessed the immunogenicity of a candidate vaccine (Priorix(TM), GlaxoSmithKline Vaccines [MMR-RIT]...

Descripción completa

Detalles Bibliográficos
Autores principales: Mufson, Maurice A., Diaz, Clemente, Leonardi, Michael, Harrison, Christopher J., Grogg, Stanley, Carbayo, Antonio, Carlo-Torres, Simon, JeanFreau, Robert, Quintero-Del-Rio, Ana, Bautista, Gisele, Povey, Michael, Da Costa, Christopher, Nicholson, Ouzama, Innis, Bruce L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681379/
https://www.ncbi.nlm.nih.gov/pubmed/26582873
http://dx.doi.org/10.1093/jpids/piu081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681379/
https://www.ncbi.nlm.nih.gov/pubmed/26582873
http://dx.doi.org/10.1093/jpids/piu081

Ejemplares similares